Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 132

1.

Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies.

Bras J, Guerreiro R, Darwent L, Parkkinen L, Ansorge O, Escott-Price V, Hernandez DG, Nalls MA, Clark LN, Honig LS, Marder K, Van Der Flier WM, Lemstra A, Scheltens P, Rogaeva E, St George-Hyslop P, Londos E, Zetterberg H, Ortega-Cubero S, Pastor P, Ferman TJ, Graff-Radford NR, Ross OA, Barber I, Braae A, Brown K, Morgan K, Maetzler W, Berg D, Troakes C, Al-Sarraj S, Lashley T, Compta Y, Revesz T, Lees A, Cairns N, Halliday GM, Mann D, Pickering-Brown S, Dickson DW, Singleton A, Hardy J.

Hum Mol Genet. 2014 Jun 27. pii: ddu334. [Epub ahead of print]

PMID:
24973356
[PubMed - as supplied by publisher]
Free Article
2.

Exome sequencing identifies 2 novel presenilin 1 mutations (p.L166V and p.S230R) in British early-onset Alzheimer's disease.

Sassi C, Guerreiro R, Gibbs R, Ding J, Lupton MK, Troakes C, Lunnon K, Al-Sarraj S, Brown KS, Medway C, Lord J, Turton J, Mann D, Snowden J, Neary D, Harris J, Bras J; ARUK Consortium, Morgan K, Powell JF, Singleton A, Hardy J.

Neurobiol Aging. 2014 Oct;35(10):2422.e13-6. doi: 10.1016/j.neurobiolaging.2014.04.026. Epub 2014 May 2.

PMID:
24880964
[PubMed - in process]
Free Article
3.

Safety, pharmacokinetic, and functional effects of the nogo-a monoclonal antibody in amyotrophic lateral sclerosis: a randomized, first-in-human clinical trial.

Meininger V, Pradat PF, Corse A, Al-Sarraj S, Rix Brooks B, Caress JB, Cudkowicz M, Kolb SJ, Lange D, Leigh PN, Meyer T, Milleri S, Morrison KE, Orrell RW, Peters G, Rothstein JD, Shefner J, Lavrov A, Williams N, Overend P, Price J, Bates S, Bullman J, Krull D, Berges A, Abila B, Meno-Tetang G, Wurthner J.

PLoS One. 2014 May 19;9(5):e97803. doi: 10.1371/journal.pone.0097803. eCollection 2014.

PMID:
24841795
[PubMed - in process]
Free PMC Article
4.

Epigenomic and transcriptomic signatures of a Klinefelter syndrome (47,XXY) karyotype in the brain.

Viana J, Pidsley R, Troakes C, Spiers H, Wong CC, Al-Sarraj S, Craig I, Schalkwyk L, Mill J.

Epigenetics. 2014 Apr 1;9(4):587-99. doi: 10.4161/epi.27806. Epub 2014 Jan 29.

PMID:
24476718
[PubMed - in process]
Free Article
5.

Two cases of multinodular and vacuolating neuronal tumour.

Bodi I, Curran O, Selway R, Elwes R, Burrone J, Laxton R, Al-Sarraj S, Honavar M.

Acta Neuropathol Commun. 2014 Jan 20;2(1):7. doi: 10.1186/2051-5960-2-7.

PMID:
24444358
[PubMed]
Free PMC Article
6.

TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions.

Gallagher MD, Suh E, Grossman M, Elman L, McCluskey L, Van Swieten JC, Al-Sarraj S, Neumann M, Gelpi E, Ghetti B, Rohrer JD, Halliday G, Van Broeckhoven C, Seilhean D, Shaw PJ, Frosch MP, Alafuzoff I, Antonell A, Bogdanovic N, Brooks W, Cairns NJ, Cooper-Knock J, Cotman C, Cras P, Cruts M, De Deyn PP, DeCarli C, Dobson-Stone C, Engelborghs S, Fox N, Galasko D, Gearing M, Gijselinck I, Grafman J, Hartikainen P, Hatanpaa KJ, Highley JR, Hodges J, Hulette C, Ince PG, Jin LW, Kirby J, Kofler J, Kril J, Kwok JB, Levey A, Lieberman A, Llado A, Martin JJ, Masliah E, McDermott CJ, McKee A, McLean C, Mead S, Miller CA, Miller J, Munoz DG, Murrell J, Paulson H, Piguet O, Rossor M, Sanchez-Valle R, Sano M, Schneider J, Silbert LC, Spina S, van der Zee J, Van Langenhove T, Warren J, Wharton SB, White CL 3rd, Woltjer RL, Trojanowski JQ, Lee VM, Van Deerlin V, Chen-Plotkin AS.

Acta Neuropathol. 2014 Mar;127(3):407-18. doi: 10.1007/s00401-013-1239-x. Epub 2014 Jan 19.

PMID:
24442578
[PubMed - in process]
Free PMC Article
7.

Neuron-specific alterations in signal transduction pathways associated with Alzheimer's disease.

Gerschütz A, Heinsen H, Grünblatt E, Wagner AK, Bartl J, Meissner C, Fallgatter AJ, Al-Sarraj S, Troakes C, Ferrer I, Arzberger T, Deckert J, Riederer P, Fischer M, Tatschner T, Monoranu CM.

J Alzheimers Dis. 2014;40(1):135-42. doi: 10.3233/JAD-131280.

PMID:
24334724
[PubMed - in process]
8.

Simulated surgical-type cerebral biopsies from post-mortem brains allows accurate neuropathological diagnoses in the majority of neurodegenerative disease groups.

King A, Maekawa S, Bodi I, Troakes C, Curran O, Ashkan K, Al-Sarraj S.

Acta Neuropathol Commun. 2013 Aug 19;1(1):53. doi: 10.1186/2051-5960-1-53.

PMID:
24252649
[PubMed]
Free PMC Article
9.

Primary glioblastoma with oligodendroglial differentiation has better clinical outcome but no difference in common biological markers compared with other types of glioblastoma.

Laxton RC, Popov S, Doey L, Jury A, Bhangoo R, Gullan R, Chandler C, Brazil L, Sadler G, Beaney R, Sibtain N, King A, Bodi I, Jones C, Ashkan K, Al-Sarraj S.

Neuro Oncol. 2013 Dec;15(12):1635-43. doi: 10.1093/neuonc/not125. Epub 2013 Oct 24.

PMID:
24158110
[PubMed - indexed for MEDLINE]
10.

Neuron-specific mitochondrial DNA deletion levels in sporadic Alzheimer's disease.

Gerschütz A, Heinsen H, Grünblatt E, Wagner AK, Bartl J, Meissner C, Fallgatter AJ, Al-Sarraj S, Troakes C, Ferrer I, Arzberger T, Deckert J, Riederer P, Fischer M, Tatschner T, Monoranu CM.

Curr Alzheimer Res. 2013 Dec;10(10):1041-6.

PMID:
24156256
[PubMed - in process]
11.

Alzheimer's disease susceptibility variants in the MS4A6A gene are associated with altered levels of MS4A6A expression in blood.

Proitsi P, Lee SH, Lunnon K, Keohane A, Powell J, Troakes C, Al-Sarraj S, Furney S, Soininen H, Kłoszewska I, Mecocci P, Tsolaki M, Vellas B, Lovestone S, Hodges A; AddNeuroMed Consortium.

Neurobiol Aging. 2014 Feb;35(2):279-90. doi: 10.1016/j.neurobiolaging.2013.08.002. Epub 2013 Sep 21.

PMID:
24064185
[PubMed - in process]
12.

Distinct phenotypic differences associated with differential amplification of receptor tyrosine kinase genes at 4q12 in glioblastoma.

Burford A, Little SE, Jury A, Popov S, Laxton R, Doey L, Al-Sarraj S, Jürgensmeier JM, Jones C.

PLoS One. 2013 Aug 21;8(8):e71777. doi: 10.1371/journal.pone.0071777. eCollection 2013.

PMID:
23990986
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Atypical progressive supranuclear palsy presenting as primary lateral sclerosis.

King A, Curran O, Al-Sarraj S.

J Neurol Sci. 2013 Jun 15;329(1-2):69. doi: 10.1016/j.jns.2013.03.015. Epub 2013 Apr 6. No abstract available.

PMID:
23570981
[PubMed - indexed for MEDLINE]
14.

IDH1-associated primary glioblastoma in young adults displays differential patterns of tumour and vascular morphology.

Popov S, Jury A, Laxton R, Doey L, Kandasamy N, Al-Sarraj S, Jürgensmeier JM, Jones C.

PLoS One. 2013;8(2):e56328. doi: 10.1371/journal.pone.0056328. Epub 2013 Feb 22.

PMID:
23451042
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Accuracy of the National Institute for Neurological Disorders and Stroke/Society for Progressive Supranuclear Palsy and neuroprotection and natural history in Parkinson plus syndromes criteria for the diagnosis of progressive supranuclear palsy.

Respondek G, Roeber S, Kretzschmar H, Troakes C, Al-Sarraj S, Gelpi E, Gaig C, Chiu WZ, van Swieten JC, Oertel WH, Höglinger GU.

Mov Disord. 2013 Apr;28(4):504-9. doi: 10.1002/mds.25327. Epub 2013 Feb 21.

PMID:
23436751
[PubMed - indexed for MEDLINE]
16.

Papillary glioneuronal tumour: a review of the literature with two illustrative cases.

Demetriades AK, Al Hyassat S, Al-Sarraj S, Bhangoo RS, Ashkan K.

Br J Neurosurg. 2013 Jun;27(3):401-4. doi: 10.3109/02688697.2012.741735. Epub 2012 Nov 22. Review.

PMID:
23173837
[PubMed - indexed for MEDLINE]
17.

Role of platelet derived growth factor receptor (PDGFR) over-expression and angiogenesis in ependymoma.

Moreno L, Popov S, Jury A, Al Sarraj S, Jones C, Zacharoulis S.

J Neurooncol. 2013 Jan;111(2):169-76. doi: 10.1007/s11060-012-0996-z. Epub 2012 Nov 8.

PMID:
23135775
[PubMed - indexed for MEDLINE]
18.

Mixed tau, TDP-43 and p62 pathology in FTLD associated with a C9ORF72 repeat expansion and p.Ala239Thr MAPT (tau) variant.

King A, Al-Sarraj S, Troakes C, Smith BN, Maekawa S, Iovino M, Spillantini MG, Shaw CE.

Acta Neuropathol. 2013 Feb;125(2):303-10. doi: 10.1007/s00401-012-1050-0. Epub 2012 Sep 28.

PMID:
23053136
[PubMed - indexed for MEDLINE]
19.

Transportin 1 colocalization with Fused in Sarcoma (FUS) inclusions is not characteristic for amyotrophic lateral sclerosis-FUS confirming disrupted nuclear import of mutant FUS and distinguishing it from frontotemporal lobar degeneration with FUS inclusions.

Troakes C, Hortobágyi T, Vance C, Al-Sarraj S, Rogelj B, Shaw CE.

Neuropathol Appl Neurobiol. 2013 Aug;39(5):553-61. doi: 10.1111/j.1365-2990.2012.01300.x.

PMID:
22934812
[PubMed - indexed for MEDLINE]
20.

The genetics and neuropathology of amyotrophic lateral sclerosis.

Al-Chalabi A, Jones A, Troakes C, King A, Al-Sarraj S, van den Berg LH.

Acta Neuropathol. 2012 Sep;124(3):339-52. doi: 10.1007/s00401-012-1022-4. Epub 2012 Aug 2. Review.

PMID:
22903397
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk